Search Results 41-50 of 28817 for Lupus

1. In the Loop: Curling for a Cause: 'Lupus 'Spiel USA' Raises Funds for Research - Mayo Clinic News Network

   Share this: ... This story originally appeared on the In the Loop blog. Regan Birr was diagnosed with lupus when she was 21 years old. In the years since, she ...

2. A Study of the Safety and Tolerability of JNJ-55920839, Either as a Single Ascending Dose in Healthy Individuals or as Multiple Doses for Patients who have Mild to Moderate Systemic Lupus Erythematosus - Mayo Clinic

   ... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...

3. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus ...

4. Mayo Clinic Radio: Awareness Saturday — Arthritis / Osteoporosis / Lupus

   Vaidehi Chowdhary explains the importance of recognizing those who suffer from the chronic inflammatory disease lupus. Listen to the program on Saturday, May 21 ...

5. Sjogren's syndrome - Symptoms and causes - Mayo Clinic

   The condition often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. In Sjogren's syndrome, the mucous membranes and ...

6. Transverse myelitis - Symptoms & causes - Mayo Clinic

   These disorders include lupus, which can affect multiple body systems, and Sjogren's syndrome, which causes severe dryness of the mouth and eyes. Transverse ...

7. A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

   Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...

8. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

   Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).

9. Ali A. Duarte Garcia, M.D. - Doctors and Medical Staff - Mayo Clinic

   Diagnosis, evaluation and management of systemic lupus erythematosus and antiphospholipid syndrome. Complex evaluation and coordination of care for patients ...

10. Mayo Clinic: Big Toe Isn't Biggest Culprit in Gout Flare-Ups; Other Joints Tied to Higher Risk

    In other findings, Mayo discovered a clue to why lupus tends to be worse in African-Americans; chronicled erratic blood pressure in rheumatoid arthritis ...